<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03558009</url>
  </required_header>
  <id_info>
    <org_study_id>EHA 01-2018</org_study_id>
    <nct_id>NCT03558009</nct_id>
  </id_info>
  <brief_title>Epidemiological Analysis for Hereditary Angioedema Disease</brief_title>
  <acronym>EHA</acronym>
  <official_title>Epidemiological Analysis for Hereditary Angioedema Disease: An International, Multicenter, Epidemiological Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centogene AG Rostock</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centogene AG Rostock</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An international, multicenter, epidemiological, observational study investigating the
      prevalence of Hereditary Angioedema (HAE) disease among participants with recurrent episodes
      of abdominal pain of no obvious etiology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hereditary Angioedema (HAE) is a rare autosomal dominant disorder characterized most commonly
      by deficient (type 1) or nonfunctional (type 2) C1 inhibitor protein (encoded by SERPING1
      gene). The disorder is associated with episodes of angioedema of the face, larynx, lips,
      abdomen, and extremities. The angioedema is caused by the activation of the kallikrein-kinin
      system that leads to the release of vasoactive peptides, followed by edema, which in severe
      cases can be life threatening.

      Gastrointestinal involvement occurs in 93% of patients with HAE and may be the only
      manifestation of the disease. However, individuals with gastrointestinal symptoms are rarely
      considered for HAE and the disease can be misdiagnosed for several years.

      EHA study focuses on the gastrointestinal complications of HAE as a potential area of
      misdiagnosis leading to surgical morbidity. Aim of the study is to investigate the prevalence
      of HAE among participants experiencing recurrent abdominal pain attacks with no clear
      etiology. The HAE-positive samples in the study will be further analyzed biochemically to
      identify disease-specific biomarker that may support the development of new diagnostic tools
      for HAE disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epidemiological analysis of prevalence of the HAE in participants with previous episodes of abdominal pain of no obvious etiology.</measure>
    <time_frame>4 years</time_frame>
    <description>Dry Blood Spot (DBS)-based biochemical measurements of C4 complement and the protease C1 inhibitor levels will be analyzed via liquid chromatography multiple reaction. The pathological biochemical results will be genetically validated via combination of the Next-Generation Sequencing (the mutation will be confirmed by Sanger sequencing) and Multiplex ligation-dependent probe amplification of SERPING1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establishment of a biomarker in HAE-positive cohort</measure>
    <time_frame>4 years</time_frame>
    <description>HAE-positive samples will be analyzed for the identification of potential biomarkers (based on MS/MS-Tandem spectroscopy) and compared with the merged control samples in order establish a HAE specific biomarker.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Abdominal Pain</condition>
  <condition>Functional Abdominal Pain</condition>
  <arm_group>
    <arm_group_label>Participants with abdominal pain attacks</arm_group_label>
    <description>Participants experiencing recurrent abdominal pain attacks without a clear etiolgy aged between 2-60 years</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample applied on the Dry Blood Spot (DBS) Filtercard (Centocard®)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with previous episodes of abdominal pain attacks of no obvious etiology
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          -  Informed consent will be obtained from the participant or the parent or legal guardian

          -  Participants with previous episodes of abdominal pain of no obvious etiology

          -  Participants aged between 2 to 60 years old

        EXCLUSION CRITERIA

          -  Previous diagnosis of HAE

          -  Inability to provide informed consent

          -  The etiology of abdominal pain attacks is determined

          -  Participants that are younger than 2 years old or older than 60 years old

          -  Previous enrolled in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arndt Rolfs, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centogene AG Rostock</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Volha Skrahina, PhD</last_name>
    <phone>+49 (0)38180113594</phone>
    <email>Volha.Skrahina@centogene.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Selen Zülbahar, PhD</last_name>
    <phone>+49 (0)38180113590</phone>
    <email>Selen.Zuelbahar@centogene.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Allgemein-, Viszeral- und Kinderchirurgie</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wolfram T. Knoefel, MD</last_name>
      <phone>+49 (0)22181173501</phone>
      <email>knoefel@uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Wolfram T. Knoefel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Gastroenterologie und Hepatologie am Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Albrecht Hoffmeister, MD</last_name>
      <phone>+49 (0)3419712226</phone>
      <email>albrecht.hoffmeister@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Albrecht Hoffmeister, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinder- und Jugendklinik, Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Däbritz, MD</last_name>
      <phone>+49 (0)3814947001</phone>
      <email>Jan.Daebritz@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Jan Däbritz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Antonio Cardarelli</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Del Mastro, MD</last_name>
      <phone>+39 (0)817472888</phone>
      <email>andreadelma84@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrea Del Mastro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hiroshima University Graduate School of Biomedical Sciences</name>
      <address>
        <city>Hiroshima</city>
        <zip>7348551</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michihiro Hide, MD</last_name>
      <phone>+81 (0)822575235</phone>
      <email>ed1h-w1de-road@hiroshima-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Michihiro Hide, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hikita Pediatric Clinic</name>
      <address>
        <city>Kiryū</city>
        <zip>6638131</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshiyuki Hikita, MD</last_name>
      <email>thikita@ra2.sonet.ne.jp</email>
    </contact>
    <investigator>
      <last_name>Toshiyuki Hikita, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Alfamedica Silesia North</name>
      <address>
        <city>Częstochowa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Gonciarz, MD</last_name>
      <phone>+48 (0)343147107</phone>
      <email>zaneta.antonska@alfamedica.med.pl</email>
    </contact>
    <investigator>
      <last_name>Maciej Gonciarz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialized Medical Offices MeaMedica</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-244</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Kuziemski, Prof.</last_name>
      <phone>+48 (0)602185094</phone>
      <email>k.kuziemski@gumed.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Kuziemski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PrzychodniaLekarskaMediSpace</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michał Wszoła, MD</last_name>
      <email>ewa.wszola@medispace.pl</email>
    </contact>
    <investigator>
      <last_name>Michał Wszoła, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elżbieta Poniewierka, MD</last_name>
      <phone>+48 (0)717332120</phone>
      <email>eponiewierka@usk.wroc.pl</email>
    </contact>
    <investigator>
      <last_name>Elżbieta Poniewierka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Koc University Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bülent Baran, MD</last_name>
      <phone>+90 (0)2124678700</phone>
      <email>bbaran@ku.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Bülent Baran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylül University Research and Application Hospital</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Göksel Bengi, MD</last_name>
      <phone>+90 (0)2324123713</phone>
      <email>goksel.bengi@deu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Göksel Bengi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aberdeen Royal Infirmary</name>
      <address>
        <city>Aberdeen</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University Hospital of Derby and Burton NHS Foundation Trust</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Crosshouse</name>
      <address>
        <city>Kilmarnock</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St George's University Hospital London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>The Royal London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Milton Keynes Hospital</name>
      <address>
        <city>Milton Keynes</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Poland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.centogene.com/clinical-studies/hereditary-angioedema-disease.html</url>
    <description>Related info.</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hereditary Angioedema</keyword>
  <keyword>DBS-based biochemical and genetic assay for HAE type I/II</keyword>
  <keyword>Biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angioedema</mesh_term>
    <mesh_term>Angioedemas, Hereditary</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

